[CAS NO. 36840-10-5] LPA2antagonist2
PRODUCTS SPECIFICATIONS [36840-10-5]
DESCRIPTION [36840-10-5]
Overview
| MDL | MFCD00566434 |
|---|---|
| Molecular Weight | 380.35 |
| Molecular Formula | C20H16N2O6 |
| SMILES | O=C(O)/C=C/C(NC1=CC=C(C2=CC=C(NC(/C=C/C(O)=O)=O)C=C2)C=C1)=O |
Summary
LPA2 antagonist 2 (H2L 5226501) is a selective LPA 2 antagonist with an IC 50 of 28.3 nM and a K i of 21.1 nM. LPA2 antagonist 2 is >480-fold more selective than LPA 3 ( IC 50 of 13.85 μM) [1] .
IC50 & Target
IC50: 28.3 nM (LPA 2 ); 13.85 μM (LPA 3 ) [1]
In Vitro
Lysophosphatidic acid (LPA) is a phospholipid mediator that elicits a host of biological effects including cell proliferation, survival, motility and differentiation. LPA has been shown to regulate cancer cell invasion, metastasis, and resistance to both chemotherapeutics and radiation. LPA2 antagonist 2 (H2L 5226501) inhibits LPA 1 with an Imax of 59.0% at 30 µM [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
DMSO : 83.33 mg/mL ( 219.09 mM ; Need ultrasonic)
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.6292 mL | 13.1458 mL | 26.2916 mL |
| 5 mM | 0.5258 mL | 2.6292 mL | 5.2583 mL |
| 10 mM | 0.2629 mL | 1.3146 mL | 2.6292 mL |
